Furans
Medchemexpress LLC WST-1 | 150849-52-8 | 97.3% | 651.34 | 50 MG
WST-1 is a water-soluble tetrazolium salt that induces intracellular mitochondrial dehydrogenase to conduct an NADH-dependent enzyme digestion reaction, releasing a water-soluble methyl benzene product. It can be used for the detection of cell proliferation and cytotoxicity by determining the light absorption value at 450 nm. This product is for research use only.
- Water-soluble tetrazolium salt
- Induces intracellular mitochondrial dehydrogenase activity
- Releases a water-soluble methyl benzene product
- Suitable for detection of cell proliferation
- Suitable for cytotoxicity analysis
- Determines light absorption value at 450 nm
- Used in cell staining analysis
- Relevant for cell function analysis
- Considered a cell viability dye
Medchemexpress LLC 1-aminohydantoin hydrochloride | 2827-56-7 | MFCD02181047 | ≥98.0% | 151.55 | C3H6ClN3O2 | 500mg
1-Aminohydantoin hydrochloride (Standard) is the analytical standard of 1-Aminohydantoin hydrochloride (HY-Y0469) This product is intended for research and analytical applications 1-Aminohydantoin hydrochloride is a major metabolite of Nitrofurantoin (HY-A0090) in animal tissues and can be used as a standard for the determination of residues of veterinary agents in meat milk et al 1-Aminohydantoin hydrochloride covalently binds to tissue proteins and is released from the tissues under slightly acidic conditions and derivatized with 2-nitrobenzaldehyde to form nitrophenyl derivatives of 1-Aminohydantoin hydrochloride before detection[1][2]
Medchemexpress LLC N-(3-(4-amino-7-(2-deoxy-pentofuranosyl)-prop-2-yn-1-yl)-2,2,2-trifluoroacetamide | 178420-75-2 | MFCD29904589 | 98.8% | 399.32 g·mol⁻¹ | C16H16F3N5O4 | 5 MG
7-TFA-ap-7-Deaza-dA is a modified deoxynucleoside that contains an alkyne functional group for bioorthogonal labeling. It is intended for incorporation into DNA or RNA and for conjugation via copper-catalyzed azide-alkyne cycloaddition (CuAAC), supplied as a well-characterized solid or as a DMSO solution for synthesis and labeling workflows.
- High purity of 98.8% for reliable synthetic use.
- Alkyne handle enables CuAAC click chemistry conjugation.
- Compatible with DNA and RNA synthesis protocols.
- Available as solid or as 10 mM solution in DMSO for convenience.
- Characterized molecular weight and formula for analytical confirmation.
Medchemexpress LLC PAR-2-IN-1 | 1690176-75-0 | 98.9% | 267.71 | 50 MG
PAR-2-IN-1 is a protease-activated receptor-2 (PAR2) signaling pathway inhibitor. It demonstrates anti-inflammatory and anticancer effects.
- Protease-activated receptor-2 (PAR2) signaling pathway inhibitor
- Exhibits anti-inflammatory effects
- Demonstrates anticancer effects
- Related to cancer targeted therapy and cancer metabolism
- Acts on GPCR/G protein and protease activated receptor (PAR) pathways
![Medchemexpress LLC Methyl 8-(tert-butyl)-6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | 1690176-75-0 | MFCD28144723 | 99.8% | C12H14ClN3O2 | 10MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000260296.png-250.jpg)
Medchemexpress LLC Methyl 8-(tert-butyl)-6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | 1690176-75-0 | MFCD28144723 | 99.8% | C12H14ClN3O2 | 10MG
PAR-2-IN-1 is a small-molecule inhibitor of protease-activated receptor 2 (PAR2) signaling with reported anti-inflammatory and anticancer effects. The compound is supplied as a solid research reagent with defined solubility in DMSO and formulation examples for in vivo studies.
- Selective PAR2 pathway inhibitor.
- Demonstrated anti-inflammatory and anticancer activity in preclinical studies.
- High purity (99.8%).
- Soluble in DMSO (~83.33 mg/mL) and formulatable for in vivo use.
- Supplied as a stable powder with recommended storage at -20°C.
- Available in multiple research quantities.
Medchemexpress LLC (3Z)-3-(2-pyridinylmethylene)-1,3-dihydro-2H-indol-2-one | 187325-53-7 | MFCD00435358 | 98.0% | 222.25 | C14H10N2O | 10MG
GSK-3β inhibitor 1 is a potent small-molecule inhibitor of glycogen synthase kinase-3β (compound 3a) with an enzymatic IC50 of 4.19 nM and demonstrated antidiabetic efficacy in streptozotocin-treated obese rat models. The compound is provided as a high-purity research chemical (98.04%) in solid form and as DMSO solutions, and is suitable for in vitro and in vivo research applications.
- Potent enzymatic inhibition (IC50 = 4.19 nM).
- Demonstrated antidiabetic efficacy in animal models.
- High purity suitable for research applications.
- Available as solid and DMSO solution formats.
- Supplied in multiple sizes for scalable experiments.
- Molecular weight 222.25 g·mol⁻¹; formula C14H10N2O.
eMolecules 1314118-94-9 | MK2-IN-1 hydrochloride | MFCD29472226 | 25mg
ChemScene | (S)-tert-Butyl (3-hydroxy-11-diphenylpropan-2-yl)carbamate | 100mg | 694122996 | CS-W013937 | 155836-47-8 | MFCD01863566 | 327.424 | C20H25NO3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC SID7970631 | 868224-75-3 | 98.3% | 50 MG
SID7970631, an isoquinolinone analog, is a potent and selective submicromolar SF-1 inhibitor with an IC50 of 255 nM. It is used for cancer research.
- Potent and selective submicromolar SF-1 inhibitor (IC50 of 255 nM)
- Used for cancer research
- Exhibits a half-maximal cytotoxic effect in CHO-K1 cells
- Dose-dependently inhibits luciferase expression in the SF-1 assay
- Shows cytotoxic effects on H295R/TR SF-1 cells and SW-13 cells
- Molecular weight is 452.46 with the formula C24H24N2O7
- Appears as a white to off-white solid
- Soluble in DMSO at 100 mg/mL
Medchemexpress LLC Epoxiconazole | 133855-98-8 | 99.0% | 10MG
Epoxiconazole | 133855-98-8 | 99.0% | 10MG
Apexbio Technology LLC Azimilide 149908-53-2 5mg
Azimilide (CAS 149908-53-2) is a small molecule under investigation for potential anti-arrhythmic activity classified pharmacologically as a class III anti-arrhythmic agent Its mechanism involves inhibition of cardiac delayed rectifier potassium channels specifically targeting both rapid (IKr) and slow (IKs) components By modulating these currents azimilide prolongs cardiac repolarization influencing cardiac rhythm Although not approved for therapeutic use azimilide is currently undergoing clinical evaluation in the United States and serves as a tool compound in arrhythmia-related biomedical research
Selleck Chemical LLC Dantrolene sodium
Dantrolene sodium(F 440) acts as a postsynaptic muscle relaxant by inhibiting Ca2 ions release from sarcoplasmic reticulum stores by antagonizing ryanodine receptors
Sigma Aldrich Fine Chemicals Biosciences C646 >=98% (HPLC) | 328968-36-1 | MFCD01784780 | 25MG
C646 >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 445.42 | 328968-36-1 | MFCD01784780 | 25MG
